[F:1][C:2]([F:24])([F:23])[C:3]1[CH:4]=[C:5]2[CH:11]=[C:10]([C:12]([O:14]CC)=O)[N:9]([CH2:17][C:18]3[S:19][CH:20]=[CH:21][N:22]=3)[C:6]2=[N:7][CH:8]=1.[NH:25]1[C:29]2=[N:30][CH:31]=[C:32]([NH2:34])[CH:33]=[C:28]2[CH:27]=[CH:26]1.C[Al](C)C>>[NH:25]1[C:29]2=[N:30][CH:31]=[C:32]([NH:34][C:12]([C:10]3[N:9]([CH2:17][C:18]4[S:19][CH:20]=[CH:21][N:22]=4)[C:6]4=[N:7][CH:8]=[C:3]([C:2]([F:24])([F:23])[F:1])[CH:4]=[C:5]4[CH:11]=3)=[O:14])[CH:33]=[C:28]2[CH:27]=[CH:26]1Compound 30 was prepared according to a process similar to that described in step 5.1 by reacting 186 mg (0.523 mmol) of ethyl 5-trifluoromethyl-1-[(thiazol-2-yl)methyl]-1H-pyrrolo[2,3-b]pyridine-2-carboxylate prepared according to the protocol described in step 7.1 with 84 mg (0.628 mmol) of pyrrolo[2,3-b]pyrid-5-ylamine in the presence of 0.39 mL (0.785 mmol) of a solution of trimethylaluminium (2M/toluene). The product is collected by filtration, to give 144 mg of expected product.
Loading…